A Randomised, 2-period, Cross-over study to evaluate the bioequivalence and relative bioavailability of abiraterone acetate fine particle with methylprednisolone versus the reference product with prednisone in healthy subjects
Latest Information Update: 12 Jan 2018
At a glance
- Drugs Abiraterone acetate (Primary) ; Methylprednisolone; Prednisone
- Indications Prostate cancer
- Focus Pharmacokinetics
- 21 Jun 2017 New trial record
- 06 Jun 2017 Results presented at the 53rd Annual Meeting of the American Society of Clinical Oncology